Understanding the Acceptability of Broadly Neutralizing Antibodies for HIV Prevention Among At-Risk Populations and Feasibility Considerations for Product Introduction in India: Protocol for a Qualitative Study

Understanding the Acceptability of Broadly Neutralizing Antibodies for HIV Prevention Among At-Risk Populations and Feasibility Considerations for Product Introduction in India: Protocol for a Qualitative Study

BackgroundAcceptability and preference research play a crucial role in the design, evaluation, and implementation of any new prevention product in any geographical setting. They also play a critical role in the development of clinical guidelines and policies. A wide range of...

Full description

Bibliographic Details
Main Authors:	Joyeeta Mukherjee, Shruta Rawat, Saif ul Hadi, Pritha Aggarwal, Venkatesan Chakrapani, Pratyasha Rath, Pallavi Manchi, Srikrishnan Aylur, Shelly Malhotra, Margaret Keane, Alok Gangaramany
Format:	Article
Language:	English
Published:	JMIR Publications 2024-02-01
Series:	JMIR Research Protocols
Online Access:	https://www.researchprotocols.org/2024/1/e47700

Similar Items

Mental health, economic well-being and health care access amid the COVID-19 pandemic: a mixed methods study among urban men who have sex with men in India
by: Venkatesan Chakrapani, et al.
Published: (2022-12-01)

Neutralization diversity of HIV-1 Indian subtype C envelopes obtained from cross sectional and followed up individuals against broadly neutralizing monoclonal antibodies having distinct gp120 specificities
by: Ranajoy Mullick, et al.
Published: (2021-05-01)

A scoping review of lesbian, gay, bisexual, transgender, queer, and intersex (LGBTQI+) people's health in India.
by: Venkatesan Chakrapani, et al.
Published: (2023-01-01)

A scoping review of lesbian, gay, bisexual, transgender, queer, and intersex (LGBTQI+) people’s health in India
by: Venkatesan Chakrapani, et al.
Published: (2023-01-01)

Engagement of vulnerable communities in HIV prevention research in India: a qualitative investigation
by: Venkatesan Chakrapani, et al.
Published: (2024-01-01)

An eHealth Intervention for Promoting COVID-19 Knowledge and Protective Behaviors and Reducing Pandemic Distress Among Sexual and Gender Minorities: Protocol for a Randomized Controlled Trial (#SafeHandsSafeHearts)
by: Peter A Newman, et al.
Published: (2021-12-01)

Broadly Neutralizing Synthetic Cannabinoid Vaccines
by: Mingliang Lin, et al.
Published: (2020-12-01)

Development of broadly neutralizing antibodies in HIV-1 infected elite neutralizers
by: Elise Landais, et al.
Published: (2018-09-01)

The expanding array of HIV broadly neutralizing antibodies
by: Laura E. McCoy
Published: (2018-10-01)

Broadly Neutralizing Antibodies for HIV-1 Prevention
by: Stephen R. Walsh, et al.
Published: (2021-07-01)

Application of the SLAPNAP statistical learning tool to broadly neutralizing antibody HIV prevention research
by: Brian D. Williamson, et al.
Published: (2023-09-01)

Contribution of rare mutational outcomes to broadly neutralizing antibodies
by: Feng Anqi, et al.
Published: (2022-06-01)

Optimizing immunization protocols to elicit broadly neutralizing antibodies
by: Sprenger, Kayla G, et al.
Published: (2021)

Cross-reactive broadly neutralizing antibodies: timing is everything
by: Zelda eEuler, et al.
Published: (2012-07-01)

Broad dengue neutralization in mosquitoes expressing an engineered antibody.
by: Anna Buchman, et al.
Published: (2020-01-01)

Broadly neutralizing antibodies in HIV-1 treatment and prevention
by: Rajesh Kumar, et al.
Published: (2018-08-01)

Development of a bispecific nanobody conjugate broadly neutralizes diverse SARS-CoV-2 variants and structural basis for its broad neutralization.
by: Jing Yang, et al.
Published: (2023-11-01)

Development of a bispecific nanobody conjugate broadly neutralizes diverse SARS-CoV-2 variants and structural basis for its broad neutralization
by: Jing Yang, et al.
Published: (2023-11-01)

Public discourses and government interventions behind China’s ambitious carbon neutrality goal
by: Fang Zhang, et al.
Published: (2023-11-01)

A broadly neutralizing monoclonal antibody induces broad protection against heterogeneous PRRSV strains in piglets
by: Zhigang Zhang, et al.
Published: (2021-03-01)

Computational Prediction of Broadly Neutralizing HIV-1 Antibody Epitopes from Neutralization Activity Data
by: Ferguson, Andrew L., et al.
Published: (2014)

The Effects of Somatic Hypermutation on Neutralization and Binding in the PGT121 Family of Broadly Neutralizing HIV Antibodies
by: Sok, Devin, et al.
Published: (2014)

Computational prediction of broadly neutralizing HIV-1 antibody epitopes from neutralization activity data.
by: Andrew L Ferguson, et al.
Published: (2013-01-01)

Strategies for HIV-1 vaccines that induce broadly neutralizing antibodies
by: Haynes, BF, et al.
Published: (2022)

Broadly neutralizing antibodies for HIV-1: efficacies, challenges and opportunities
by: Yubin Liu, et al.
Published: (2020-01-01)

Broadly Neutralizing Antibodies for Influenza: Passive Immunotherapy and Intranasal Vaccination
by: Mrityunjoy Biswas, et al.
Published: (2020-07-01)

Viral Vectors for the Induction of Broadly Neutralizing Antibodies against HIV
by: Sarah Wilmschen, et al.
Published: (2019-09-01)

Structural basis for broad neutralization of hepatitis C virus quasispecies.
by: Pascal Lapierre, et al.
Published: (2011-01-01)

HIV-1 cell-to-cell transmission and broadly neutralizing antibodies
by: Jérémy Dufloo, et al.
Published: (2018-07-01)

Elimination of HIV-1-infected cells by broadly neutralizing antibodies
by: Timothée Bruel, et al.
Published: (2016-03-01)

Design clues from functional constraints and broadly neutralizing antibodies
by: Dimitrov Dimiter S, et al.
Published: (2006-12-01)

Correction: Broad dengue neutralization in mosquitoes expressing an engineered antibody.
by: Anna Buchman, et al.
Published: (2020-04-01)

Development of an anti-HIV vaccine eliciting broadly neutralizing antibodies
by: Yousuf Ahmed, et al.
Published: (2017-09-01)

Pharmacokinetics and immunogenicity of broadly neutralizing HIV monoclonal antibodies in macaques.
by: Yvonne Rosenberg, et al.
Published: (2015-01-01)

Modeling neutralization kinetics of HIV by broadly neutralizing monoclonal antibodies in genital secretions coating the cervicovaginal mucosa.
by: Scott A McKinley, et al.
Published: (2014-01-01)

Correction: The Effects of Somatic Hypermutation on Neutralization and Binding in the PGT121 Family of Broadly Neutralizing HIV Antibodies.
by: Devin Sok, et al.
Published: (2013-12-01)

Epitope mapping of broadly neutralizing HIV-2 human monoclonal antibodies.
by: Kong, R, et al.
Published: (2012)

Convergent antibody responses are associated with broad neutralization of hepatitis C virus
by: Nicole E. Skinner, et al.
Published: (2023-03-01)

Optimizing clinical dosing of combination broadly neutralizing antibodies for HIV prevention.
by: Bryan T Mayer, et al.
Published: (2022-04-01)

Exploration of broadly neutralizing antibody fragments produced in bacteria for the control of HIV
by: Sarah B. Lloyd, et al.
Published: (2017-11-01)